A tirzepatide compounding pharmacy is a licensed facility that mixes tirzepatide to order. These fall into two regulatory classes, 503A and 503B, with very different oversight. Since the FDA shortage ended, neither may mass-produce copies of Mounjaro or Zepbound, which changes how you should vet any source claiming to sell it.
What is the difference between a 503A and a 503B pharmacy?
The two categories come from different parts of US drug law and carry very different standards. A 503A pharmacy compounds patient-specific prescriptions and is overseen mainly by its state board. A 503B outsourcing facility registers with the FDA, follows manufacturing-grade quality rules (current good manufacturing practice, or cGMP), and undergoes federal inspections.
| Attribute | 503A pharmacy | 503B outsourcing facility |
|---|---|---|
| Primary regulator | State pharmacy board | FDA |
| Quality standard | USP compounding standards | cGMP, like a manufacturer |
| Prescriptions | Patient-specific required | Can make office stock in batches |
| FDA inspections | Generally no | Yes, routine |
| Typical scale | Small, individual | Large batch |
Neither category may legally produce drugs that are "essentially copies" of an available, FDA-approved product, which is exactly what blanket tirzepatide compounding became once the shortage ended.
What can a compounding pharmacy still legally make after the shortage?
With tirzepatide off the shortage list since December 2024 and the enforcement grace periods closed in early 2025, the broad permission to compound tirzepatide for everyone is gone. A legitimate 503A pharmacy can still compound a patient-specific tirzepatide preparation only when a prescriber documents a genuine clinical need the commercial product cannot meet, such as a verified allergy to an excipient in the approved pen. A pharmacy that offers tirzepatide to all comers as a routine cash product is operating outside that narrow lane. The drug-level details behind this sit in our explainer on what compounded tirzepatide actually is.
How do you verify a compounding pharmacy is legitimate?
Treat verification as non-negotiable. Confirm the pharmacy holds an active license with its state board of pharmacy and that the license is in good standing. If the seller claims 503B status, check that it appears on the FDA's published list of registered outsourcing facilities. Legitimate operations require a valid prescription tied to a real clinical evaluation, list a US physical address, and employ pharmacists you can actually reach with questions. Before committing, it helps to understand how tirzepatide pricing compares across legitimate channels so an unusually low price stands out as a warning rather than a bargain.
What red flags signal an unsafe tirzepatide source?
Some warning signs reliably separate a real pharmacy from a risky storefront:
- No prescription required, or a token questionnaire with no clinician contact
- Products labeled "for research use only" or "not for human consumption"
- No verifiable US license or physical address
- Prices far below every legitimate option
- Pressure tactics, bulk discounts, or cryptocurrency-only payment
- Vials shipped from overseas with no pharmacist named
Any one of these should stop the transaction. The "research use only" label in particular is a hallmark of the grey market, not of a licensed pharmacy.
It helps to remember why these signals matter rather than just memorizing the list. A licensed pharmacy has something to lose, namely its license, so it ties dispensing to a prescription, names a responsible pharmacist, and stands behind its labeling. An operation that skips those steps has structured itself to avoid accountability, which is precisely the situation you do not want when the product is a self-injected drug. When in doubt, the safer assumption is that a missing safeguard is deliberate, and treat the absence of basic professional infrastructure as disqualifying on its own.
What questions should you ask before buying?
Ask the pharmacy to state its 503A or 503B status in writing, to name the source of its active ingredient and provide a certificate of analysis, to confirm the exact concentration in milligrams per milliliter, and to explain how the product should be stored and how long it remains stable. A trustworthy pharmacy answers these readily; evasiveness is itself an answer. For more on the storage piece, see how long compounded tirzepatide can sit out of the fridge.
What does a legitimate dispensing process look like?
A real pharmacy does not simply take an order and ship a vial. It dispenses against a valid prescription written after a clinician has reviewed your medical history, it counsels you on dosing and storage, and it labels the product with the drug name, concentration, lot number, and a beyond-use date. A pharmacist should be reachable to answer questions or take an adverse-event report, and you should be able to identify the clinician who prescribed for you. If the entire "evaluation" is a one-screen checkbox form with no way to reach a human, you are not dealing with a pharmacy operating to professional standards, no matter what the website says. The presence of these routine safeguards is one of the clearest signals separating a licensed operation from a storefront.
What about tirzepatide shipped from overseas?
Vials mailed from outside the United States sit outside the US compounding framework entirely. They are not produced by a US-licensed 503A pharmacy or 503B outsourcing facility, they are not subject to FDA inspection, and personal importation of an unapproved injectable drug is generally not lawful. Overseas suppliers also tend to overlap heavily with the research-peptide market, where products carry no accountability for sterility, identity, or dose. A domestic shipping origin and a verifiable US license should be treated as minimum requirements rather than reassuring extras.
How is this different from the grey-market peptide scene?
Websites selling "tirzepatide for research" are not pharmacies at all. They dispense without prescriptions, label products to dodge FDA oversight, and carry no accountability for purity or dose. A real compounding pharmacy operates under state or federal licensure and patient-specific prescribing; a research-peptide vendor operates outside the medical system entirely. If you are weighing where to obtain the drug safely, our overview of where to buy tirzepatide lays out the legitimate routes.
References
- FDA: clarifying policies for compounders as GLP-1 supply stabilizes
- FDA: registered human drug compounding outsourcing facilities (503B)
Frequently Asked Questions
Is a 503B pharmacy safer than a 503A?
503B facilities follow manufacturing-grade quality rules and are inspected by the FDA, so their process oversight is stricter. That does not make any specific product FDA-approved, but it is a meaningful quality signal.
Can a compounding pharmacy legally sell me tirzepatide now?
Only in narrow, patient-specific cases with a documented clinical need the approved product cannot meet. Routine bulk compounding of tirzepatide copies is no longer permitted.
How do I check a pharmacy's license?
Search your state board of pharmacy's online license lookup, and for 503B claims, cross-check the FDA's registered outsourcing-facility list.
What does "research use only" labeling mean?
It is a signal that the seller is avoiding FDA drug rules and is not operating as a licensed pharmacy. Products labeled that way are not intended or tested for human use.
This article is educational and is not medical or legal advice; verify any pharmacy's status with the appropriate regulator.
